All In Biotech

Drug Trial Radar · NCT00263393

Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)

Evaluation of a Primary Health Care Intervention for the Prevention of Cardiovascular Disease in Rural Andhra Pradesh

Last checked: Nov 20, 2026Latest source record: Sep 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 3,712 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3,712

Actual

Start

Dec 2005

Primary completion

Dec 2008

Study completion Jun 2009

Sponsor

Lead sponsor
The George InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Byrraju Foundation; The Future Forum, UK
First posted
Dec 8, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the effectiveness of a novel cardiovascular disease prevention program designed for delivery through existing primary health care services in rural villages in Andhra Pradesh. The primary aim is to increase the number of high-risk individuals in the population that are appropriately managed with proven, low-cost preventive interventions. The corresponding null hypothesis is therefore that the prevention program will result in no change in the proportion of high-risk individuals identified and treated in villages assigned to intervention compared with those villages assigned to control.

Conditions

  • Myocardial Infarction
  • Angina Pectoris
  • Cerebrovascular Accidents
  • Diabetes Mellitus

Interventions

  • ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, StatinDrug

    The first intervention was a clinical algorithm designed to enhance the identification and treatment of high-risk individuals compared to continued usual care. The algorithm was designed to be used by either physician or non-physician health care workers.

  • Health PromotionBehavioral

    The second intervention was a health promotion program designed to increase knowledge of cardiovascular risk factors compared to continued usual practices.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The proportion of high-risk individuals that have been assessed for cardiovascular riskTime frame: 12 months after intevention
  2. The proportion of individuals with correct knowledge about the effects of behavioural determinants of the risk of cardiovascular diseaseTime frame: 12 months from intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Byrraju Foundation Primary Healthcare Centres in rural West Godavari and East Godavari Dstricts

    Bhimavaram, Andhra Pradesh, India

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.